SCHEMBL7360243

SCHEMBL7360243

O=C1OCC2C3C=C[C@@H](C3)[C@H]12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 1/20 0.41
RAB9A P51151 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
USP2 O75604 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1218407 1.00 ALDH1A1 (0.41) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL10485411 1.00 ALDH1A1 (0.41) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL23106949 0.85 ALDH1A1 (0.40) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL7663419 0.83 POLB (0.35) ALDH1A1TDP1KMT2ARECQLL3MBTL1
SCHEMBL3781306 0.83 POLB (0.35) ALDH1A1TDP1KMT2ARECQLL3MBTL1
SCHEMBL14566116 0.80 ALDH1A1 (0.34) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL1217695 0.80 ALDH1A1 (0.38) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL18906485 0.77 ALDH1A1 (0.32) ALDH1A1TDP1SMN1; SMN2L3MBTL1
SCHEMBL11721786 0.72 ALDH1A1 (0.38) ALDH1A1TDP1RAB9AMEN1KMT2A
SCHEMBL22666980 0.72 ALDH1A1 (0.38) ALDH1A1TDP1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376539-B1 ANTIISCHEMIC AGENTS, CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-04-23 US disclosed
EP-1047686-A1 SUBSTITUTED BICYCLIC LACTONES Bayer Aktiengesellschaft (DE) 2000-11-02 EP disclosed
WO-1999036418-A1 SUBSTITUTED BICYCLIC LACTONES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-22 WO disclosed